Feb. 13, 2020: PrEP's psychosocial benefits; supplementing ADAP with Obamacare plans; lack of HIV and HCV testing for people who inject drugs; frailty is more common, but not more deadly, in HIV settings.
Jan. 30, 2020: Polypharmacy vs. drug interaction risk among people living with HIV as they age; cost-effectiveness of ibalizumab; PrEP persistence on Medicaid vs. private health coverage.
Taking more than five medications could be a problem. And many people with HIV are at risk of being on medication overload.
June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.
New scientific evidence suggests that the celebrity-backed diet may have significant cognitive benefits for older people living with HIV.
The case for a new measurement of HIV treatment success; PrEP and HIV incidence in Australia; benefits of moderate exercise among older people with HIV; CD4 recovery rates after long-term viral suppression.
A new study published in PLOS Pathogens reveals that a person's viral load prior to starting antiretroviral therapy directly determines his or her level of inflammation later in life.
Among HIV-positive people in Denmark, estimated survival from age 50 almost doubled from 11.8 years in 1996-1999 to 22.8 years in 2006-2014. But HIV-positive people still had shorter estimated survival than people the same age and gender in the gene...
Researchers found that certain factors played an important role in reducing survival among HIV-positive people, including co-infection with hepatitis-causing viruses, excessive intake of alcohol, substance use and tobacco smoking.
Life expectancy of HIV-positive people over age 50 rose by more than 10 years from 1996-1999 to 2006-2014, according to results of a nationwide study in Denmark.